Psychedelic Clinical Trials

283 record(s) found.

Filters: Condition: depression

Entheogen: psilocybin
Study Title: Psilocybin-assisted CBT for Depression
Start Date: Jan 01, 2023 - Last Update: July 25, 2022
Conditions: Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents
Start Date: Dec 06, 2022 - Last Update: June 30, 2022
Conditions: Suicide, Attempted, Suicide and Depression, Suicide Threat
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults
Start Date: Sep 15, 2022 - Last Update: June 30, 2022
Conditions: Anxiety and Depression
Location(s): Jamaica
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
Start Date: Sep 01, 2022 - Last Update: June 1, 2022
Conditions: Borderline Personality Disorder, Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Preoperative Ketamine and Perioperative Depression
Start Date: Aug 01, 2022 - Last Update: August 1, 2022
Conditions: Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
Start Date: Aug 01, 2022 - Last Update: July 8, 2022
Conditions: Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
Start Date: Aug 01, 2022 - Last Update: June 28, 2022
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression
Start Date: Aug 01, 2022 - Last Update: July 12, 2022
Conditions: Treatment Resistant Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A Study of a Psilocybin Analog (CYB003) in Participants With Major Depressive Disorder
Start Date: Jul 06, 2022 - Last Update: July 13, 2022
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Auditory MMN EEG in TRD in Response to Ketamine
Start Date: Jul 01, 2022 - Last Update: July 19, 2022
Conditions: Treatment-resistant Depression (TRD)
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine-Assisted PsychoTherapy ViAbility in Treating Cancer-related Emotional Distress
Start Date: Jul 01, 2022 - Last Update: April 25, 2022
Conditions: Cancer-related Problem/Condition, Depressive Symptoms, Anxiety Disorders
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression
Start Date: Jun 01, 2022 - Last Update: April 21, 2022
Conditions: Bipolar Disorder, Bipolar Depression, Bipolar I Disorder, Bipolar II Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects
Start Date: Jun 01, 2022 - Last Update: July 15, 2022
Conditions: Major Depressive Disorder
Location(s): Austria
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD
Start Date: Jun 01, 2022 - Last Update: May 19, 2022
Conditions: Treatment-Resistant Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets
Start Date: May 05, 2022 - Last Update: May 26, 2022
Conditions: Major Depressive Disorder, Healthy Controls
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial
Start Date: Apr 25, 2022 - Last Update: May 2, 2022
Conditions: Postoperative Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for OUD and Comorbid Depression (OUDCD)
Start Date: Apr 04, 2022 - Last Update: June 22, 2022
Conditions: Opioid Use Disorder, Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine and Epigenetic Aging
Start Date: Apr 01, 2022 - Last Update: April 26, 2022
Conditions: Depression, Post Traumatic Stress Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Microdosing Psychedelics to Improve Mood
Start Date: Apr 01, 2022 - Last Update: March 29, 2022
Conditions: Persistent Depressive Disorder, Dysthymia
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression
Start Date: Mar 15, 2022 - Last Update: April 11, 2022
Conditions: Treatment-resistant Depression, Major Depressive Disorder
Location(s): Taiwan
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Frontline Clinician Psilocybin Study
Start Date: Mar 03, 2022 - Last Update: July 15, 2022
Conditions: Burnout, Caregiver, Burnout, Professional, COVID-19, Depression, Post Traumatic Stress Disorder, Moral Injury
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low-Dose Intravenous Ketamine for Adolescents With Depression and Suicidal Ideation in the Emergency Department
Start Date: Mar 01, 2022 - Last Update: March 21, 2022
Conditions: Depression, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Psychological and Existential Distress in Palliative Care
Start Date: Mar 01, 2022 - Last Update: November 18, 2021
Conditions: Depression, Anxiety, Distress, Emotional
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Start Date: Feb 04, 2022 - Last Update: February 8, 2022
Conditions: Treatment Resistant Depression, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD
Start Date: Feb 01, 2022 - Last Update: June 10, 2022
Conditions: Treatment Resistant Depression
Location(s): United States, Germany, Poland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine + Mindfulness for Depression
Start Date: Feb 01, 2022 - Last Update: March 8, 2022
Conditions: Depression, Unipolar
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: KAP for Depression in Abstinent Opioid Users
Start Date: Jan 13, 2022 - Last Update: February 24, 2022
Conditions: Opioid Use Disorder, Severe, in Sustained Remission, Opioid Use Disorder, Severe, in Early Remission, Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A randomised controlled feasibility study of ketamine-assisted therapy: Does fractal priming improve treatment response in treatment-resistant depression?
Start Date: Dec 07, 2021
Conditions: treatment-resistant depression
Location(s): New Zealand, Auckland Region
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Intravenous Esketamine on Prevention of Postoperative Depression in Patients Undergoing Cardiac Surgery
Start Date: Dec 01, 2021 - Last Update: December 14, 2021
Conditions: Postoperative Depression
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine
Start Date: Nov 29, 2021 - Last Update: April 4, 2022
Conditions: Adolescent Suicide, Adolescent Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for the Treatment of Depression in Parkinson's Disease
Start Date: Nov 23, 2021 - Last Update: May 6, 2022
Conditions: Parkinson's Disease, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Treatment-Resistant Depression
Start Date: Nov 19, 2021 - Last Update: March 3, 2022
Conditions: Treatment Resistant Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effect of Ketamine on Neurological Activity as Measured by Electroencephalogram (EEG)
Start Date: Nov 09, 2021 - Last Update: June 21, 2022
Conditions: Treatment-resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)
Start Date: Oct 25, 2021 - Last Update: December 29, 2021
Conditions: Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine
Start Date: Sep 27, 2021 - Last Update: September 29, 2021
Conditions: Depressive Disorder, Treatment-Resistant
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer, a randomized double-blind study with the possibility of entering open extension.
Start Date: Sep 22, 2021
Conditions: Depressive disorder comorbid with cancer
Location(s): Czech Republic
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: Repeated Neurocognitive Measurements in Depressed Patients
Start Date: Sep 16, 2021 - Last Update: September 23, 2021
Conditions: Depression, Unipolar
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as an Adjunctive Therapy for Major Depression (2)
Start Date: Sep 13, 2021 - Last Update: September 16, 2021
Conditions: Major Depressive Episode, Unipolar Depression, Bipolar Depression
Location(s): Ireland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effectiveness of Ketamine Treatment for Three Consecutive Days in Depression
Start Date: Sep 01, 2021 - Last Update: May 19, 2022
Conditions: Depression
Location(s): Thailand
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
Start Date: Aug 15, 2021 - Last Update: September 5, 2021
Conditions: Parkinson Disease, Depression, Anxiety
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Single Ketamine Infusion Combined With Music for Suicidal Ideation
Start Date: Jul 01, 2021 - Last Update: May 7, 2021
Conditions: Suicidal Ideation, Depressive Episode
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Start Date: Jun 10, 2021 - Last Update: July 29, 2021
Conditions: Treatment-resistant Depression
Location(s): Germany
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Psilocybin Versus Ketamine in Treatment-Resistant Depression
Start Date: May 01, 2021 - Last Update: May 20, 2022
Conditions: Treatment Resistant Depression
Location(s): Czechia
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Safety and Efficacy Evaluation of S (+) - Ketamine in Children
Start Date: May 01, 2021 - Last Update: April 8, 2021
Conditions: S-ketamine, Esketamine, Acute Pain, Postoperative Pain, Analgesia, Hyperalgesia, Delirium, Depression, Anxiety, Children
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Start Date: Apr 14, 2021 - Last Update: April 15, 2022
Conditions: Major Depressive Disorder, Alcohol Use Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Reward Emotion Learning and Ketamine Study
Start Date: Apr 01, 2021 - Last Update: April 20, 2021
Conditions: Depression, Major Depressive Disorder, Treatment Resistant Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Start Date: Mar 24, 2021 - Last Update: March 24, 2022
Conditions: Depressive Symptoms, Depression, Alzheimer Disease, Mild Cognitive Impairment
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans
Start Date: Mar 17, 2021 - Last Update: February 10, 2022
Conditions: Major Depressive Disorder, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
Start Date: Mar 01, 2021 - Last Update: December 21, 2021
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
Start Date: Mar 01, 2021 - Last Update: November 1, 2021
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients
Start Date: Feb 04, 2021 - Last Update: December 23, 2021
Conditions: Major Depressive Disorder
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Oral Ketamine Trial on Adults with Treatment-Resistant Depression
Start Date: Feb 03, 2021
Conditions: Treatment-Resistant Depression
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Pharmacogenetics Associated With IV Ketamine
Start Date: Jan 21, 2021 - Last Update: August 18, 2021
Conditions: Treatment Resistant Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression
Start Date: Jan 11, 2021 - Last Update: March 23, 2022
Conditions: Depressive Disorder, Treatment-Resistant, Depressive Disorder, Major, Unipolar Depression, Depression, Bipolar
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: A randomised, double-blind, placebo-controlled trial of repeated microdoses of lysergic acid diethylamide (LSD) in healthy volunteers
Start Date: Jan 05, 2021
Conditions: Major depressive disorder
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: IM Ketamine vs Midazolam for Suicidal ER Patients
Start Date: Jan 02, 2021 - Last Update: March 10, 2022
Conditions: Depression, Unipolar, Depression, Bipolar, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
Start Date: Jan 01, 2021 - Last Update: April 5, 2022
Conditions: Major Depressive Disorder, Depression
Location(s): Sweden
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for the Treatment of Opioid Use Disorder and Depression
Start Date: Dec 17, 2020 - Last Update: January 11, 2022
Conditions: Depression, Opioid-use Disorder, Opioid Abuse
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
Start Date: Dec 17, 2020 - Last Update: July 27, 2022
Conditions: Depressive Disorder, Major, Suicidal
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The Efficacy and Safety of S-ketamine in Elective Cesarean Section
Start Date: Dec 01, 2020 - Last Update: December 8, 2020
Conditions: Anesthesia, Analgesia, Depression, Cesarean Section, Parturition
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Use of Transmucosal Ketamine in Post Stroke Depression
Start Date: Nov 30, 2020 - Last Update: April 29, 2022
Conditions: Post-stroke Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine to Prevent PPD After Cesarean
Start Date: Nov 12, 2020 - Last Update: October 11, 2021
Conditions: Postpartum Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: University of Iowa Interventional Psychiatry Service Patient Registry
Start Date: Nov 02, 2020 - Last Update: April 21, 2022
Conditions: Treatment Resistant Depression, Major Depressive Episode, Major Depression, Major Depressive Disorder, Bipolar Disorder, Bipolar Depression, Obsessive-Compulsive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Older Adults Pilot
Start Date: Oct 22, 2020 - Last Update: April 27, 2022
Conditions: Treatment Resistant Depression, Refractory Depression, Therapy-Resistant Depression, Late Life Depression, Geriatric Depression
Location(s): United States, Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Treatment Effects on Synaptic Plasticity in Depression
Start Date: Oct 09, 2020 - Last Update: June 2, 2022
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Imaging Neural Correlates of Ketamine Using PET/MR
Start Date: Oct 01, 2020 - Last Update: October 14, 2020
Conditions: Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression
Start Date: Sep 15, 2020 - Last Update: January 26, 2022
Conditions: Treatment Resistant Depression
Location(s): United States, Ireland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
Start Date: Sep 01, 2020 - Last Update: October 15, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin in Depression Resistant to Standard Treatments
Start Date: Sep 01, 2020 - Last Update: July 22, 2021
Conditions: Treatment Resistant Depression
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A randomised, placebo controlled trial of psilocybin in treatment resistant depression: A feasibility study
Start Date: Aug 27, 2020
Conditions: Major depressive disorder
Location(s): United Kingdom(United Kingdom, -, no, longer, in, EU/EstoniaA)
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant Depression
Start Date: Aug 17, 2020 - Last Update: August 4, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Opiate Suicide Study in Patients With Major Depression
Start Date: Aug 01, 2020 - Last Update: August 31, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT)
Start Date: Aug 01, 2020 - Last Update: July 22, 2020
Conditions: Depression, Bipolar, Depression, Unipolar, Major Depressive Disorder, Manic-Depressive - Now Depressed
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
Start Date: Jul 20, 2020 - Last Update: March 3, 2021
Conditions: Treatment Resistant Depression
Location(s): United States, Czechia, Ireland, Netherlands, United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin versus ketamine – fast acting antidepressant strategies in treatment-resistant depression
Start Date: Jul 14, 2020
Conditions: The study will include 60 patients with pharmaco-resistant depression (30 male, 30 female, aged 18–65). The basic inclusion criterion is the diagnosis of pharmaco-resistant moderate to severe depre...
Location(s): Czech Republic
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: A multicentre study to assess safety and efficacy of psilocybin in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)
Start Date: Jul 08, 2020
Conditions: Treatment-Resistant Depression (P-TRD)
Location(s): Portugal, Czech Republic, Denmark, Netherlands, Germany
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
Start Date: Jun 30, 2020 - Last Update: September 30, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low Dose Ketamine Infusion for the Treatment of Resistant Depression
Start Date: Jun 29, 2020 - Last Update: May 1, 2020
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression
Start Date: Jun 19, 2020 - Last Update: April 20, 2022
Conditions: Perinatal Depression, Ketamine, Postpartum Depression
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low-dose S-ketamine in Women With Prenatal Depression
Start Date: Jun 19, 2020 - Last Update: July 12, 2021
Conditions: Prenatal Depression, Ketamine, Postpartum Depression
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intravenous Ketamine Effects on Functional Neuroanatomy
Start Date: May 02, 2020 - Last Update: June 1, 2020
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)
Start Date: May 01, 2020 - Last Update: April 20, 2020
Conditions: Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Study in healthy volunteers of the safety and how the body handles PCN-101
Start Date: Mar 03, 2020
Conditions: Depression
Location(s): New Zealand, Auckland, United States of America
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
Start Date: Jan 21, 2020 - Last Update: July 7, 2022
Conditions: Depression, Major Depressive Disorder, Major Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department
Start Date: Jan 14, 2020 - Last Update: March 2, 2021
Conditions: Suicide, Suicide Threat, Depression Severe
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: mdma
Study Title: The Effect of 3, 4-Methylenedioxymethamphetamine (MDMA)-assisted therapy on Mood and Anxiety symptoms in advanced-stage Cancer Study
Start Date: Jan 06, 2020
Conditions: Depression symptoms, Anxiety symptoms, Advanced-stage cancer
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Ketamine Interleaved With Electroconvulsive Therapy for Depression
Start Date: Jan 06, 2020 - Last Update: September 9, 2021
Conditions: Depression
Location(s): Ireland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders
Start Date: Dec 04, 2019 - Last Update: January 13, 2020
Conditions: Treatment Resistant Depression, Bipolar Depression, Ketamine, Major Depressive Disorder
Location(s): Poland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Chart Review of Patients Undergoing Ketamine Infusions
Start Date: Dec 03, 2019 - Last Update: March 2, 2022
Conditions: Major Depressive Disorder, Bipolar Disorder, Obsessive-Compulsive Disorder, Post Traumatic Stress Disorder
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Single-dose Ketamine for the Reduction of Pain and Depression in the Emergency Department
Start Date: Dec 01, 2019 - Last Update: February 11, 2020
Conditions: Acute Pain, Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality
Start Date: Dec 01, 2019 - Last Update: September 27, 2019
Conditions: Treatment Resistant Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine or Placebo in Patients With Major Depression and Advanced Cancer
Start Date: Nov 19, 2019 - Last Update: August 2, 2022
Conditions: Major Depressive Disorder, Advanced Cancer
Location(s): Mexico
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Clinical Study of GH001 in Depression
Start Date: Nov 12, 2019 - Last Update: December 20, 2021
Conditions: Treatment Resistant Depression, Major Depressive Disorder, Depression
Location(s): Netherlands
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: LSD Therapy for Persons Suffering From Major Depression
Start Date: Nov 01, 2019 - Last Update: May 25, 2022
Conditions: Major Depressive Disorder
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects
Start Date: Oct 24, 2019 - Last Update: June 16, 2022
Conditions: Depression
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department
Start Date: Oct 18, 2019 - Last Update: September 1, 2020
Conditions: Depression, Depression Severe, Depression Acute, Depression and Suicide, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A Study of Psilocybin for Major Depressive Disorder (MDD)
Start Date: Oct 15, 2019 - Last Update: July 19, 2022
Conditions: Depressive Disorder, Major
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine to Improve Recovery After Cesarean Delivery - Part 1
Start Date: Oct 09, 2019 - Last Update: October 5, 2021
Conditions: Obstetric Pain, Postpartum Depression, Breastfeeding, Pain, Acute, Pain, Chronic, Obstetric Anesthesia Problems, Drug Effect, Opioid Use
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: EEG Characteristics in ECT
Start Date: Oct 01, 2019 - Last Update: June 13, 2022
Conditions: Electroconvulsive Therapy, Direct Current Electroencephalogram, Ketamine, Spreadind Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
Start Date: Sep 30, 2019 - Last Update: January 18, 2022
Conditions: Post-Traumatic Stress Disorders, Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-assisted psychotherapy for the treatment of depression and anxiety associated with life-threatening illness
Start Date: Sep 27, 2019
Conditions: Depression in terminal illness (any palliative condition including malignant and non-malignant terminal illnesses), Anxiety in terminal illness (any palliative condition including malignant and non-malignan terminal illnesses)
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery
Start Date: Aug 22, 2019 - Last Update: June 21, 2022
Conditions: Major Depressive Disorder, Surgery, Orthopedic Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: A phase 1/2 study of GH001 in patients with treatment-resistant depression
Start Date: Aug 21, 2019
Conditions: Treatment-resistant depression
Location(s): Netherlands
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: Ketamine IV Classic Protocol : Five Years Follow up
Start Date: Aug 08, 2019 - Last Update: April 1, 2021
Conditions: Major Depressive Disorder, Drug Abuse, Medications, Relapse
Location(s): Israel
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Endogenous Opioid Modulation by Ketamine
Start Date: Aug 01, 2019 - Last Update: January 28, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low dose individually-tailored subcutaneous ketamine infusion for the treatment of depression in palliative care patients
Start Date: Jul 29, 2019
Conditions: Major Depressive Disorder, Advanced life limiting illnesses
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy
Start Date: Jul 17, 2019 - Last Update: April 15, 2022
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Mood Disorders With Suicidal Ideation
Start Date: Jul 01, 2019 - Last Update: March 2, 2021
Conditions: Depressive Disorder, Major, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Biomarkers of Response to Ketamine in Depression: MRI and Blood Assays Before and After Open Label Intranasal Ketamine
Start Date: Jun 26, 2019 - Last Update: January 22, 2021
Conditions: Depressive Disorder, Treatment-Resistant
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
Start Date: Jun 25, 2019 - Last Update: September 8, 2021
Conditions: Bipolar Depression, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Clinical and neurobiological predictors of response to ketamine: towards personalized treatment of depression
Start Date: Jun 17, 2019
Conditions: Moderate to severe depression without psychotic symptoms
Location(s): Czech Republic
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: A pilot study on oral S-ketamine for depression and demoralisation in patients with advanced cancer receiving palliative care
Start Date: Jun 10, 2019 - Last Update:
Conditions: Depression and demoralisation, advanced (non-curable) cancer
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: Study of Ketamine for Youth Depression
Start Date: May 20, 2019
Conditions: Major Depressive Disorder
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: The Role of HNKs in the Antidepressant Effect of Ketamine
Start Date: May 15, 2019 - Last Update: January 22, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine and Internalizing Disorders
Start Date: Apr 29, 2019
Conditions: Depression, Post-Traumatic Stress Disorder, Obsessive-Compulsive Disorder, Phobic Disorders
Location(s): New Zealand, Otago, Canterbury
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept
Start Date: Mar 11, 2019 - Last Update: April 29, 2022
Conditions: Depressive Disorder, Major
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression
Start Date: Mar 04, 2019 - Last Update: October 19, 2021
Conditions: Post Partum Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
Start Date: Mar 01, 2019 - Last Update: January 26, 2022
Conditions: Treatment Resistant Depression
Location(s): United States, Canada, Czechia, Denmark, Germany, Ireland, Netherlands, Portugal, Spain, United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine in anorexia nervosa
Start Date: Feb 09, 2019
Conditions: anorexia nervosa, depressive disorder, anxiety disorder, obessional disorder
Location(s): New Zealand, Dunedin, Otago
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression
Start Date: Feb 08, 2019 - Last Update: October 8, 2021
Conditions: Depressive Disorder, Treatment-Resistant
Location(s): United States, Spain
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
Start Date: Jan 07, 2019 - Last Update: July 31, 2020
Conditions: Depressive Disorder, Major
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:
Start Date: Jan 03, 2019 - Last Update: September 10, 2021
Conditions: Major Depressive Disorder, Treatment Resistant Depression, Bipolar Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Major Depressive Disorder
Start Date: Dec 28, 2018 - Last Update: April 25, 2019
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Co-induction for Patients With Major Depressive Disorder
Start Date: Dec 01, 2018 - Last Update: September 13, 2018
Conditions: Ketamine, Depression, Anesthesia
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
Start Date: Nov 29, 2018 - Last Update: May 26, 2022
Conditions: Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: mdma
Study Title: Project PRIDE (Promoting Resilience In Discriminatory Environments)
Start Date: Nov 09, 2018 - Last Update: May 25, 2022
Conditions: Human Immunodeficiency Virus, Sexually Transmitted Infections, Anxiety, Depression, Substance Use Disorders
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Versus Electroconvulsive Therapy in Depression
Start Date: Oct 29, 2018 - Last Update: April 19, 2021
Conditions: Depressive Disorder, Major, Bipolar Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Evaluation of Schemes of Administration of Intravenous Ketamine in Depression
Start Date: Oct 01, 2018 - Last Update: September 10, 2019
Conditions: Treatment Resistant Depression
Location(s): Mexico
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study of Ketamine in Elderly Patients with Depression.
Start Date: Sep 24, 2018
Conditions: Depression
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Using a Low Dose of Ketamine vs. Active Placebo in Treating Severe Depression and Suicide
Start Date: Sep 10, 2018 - Last Update: September 19, 2018
Conditions: Major Depressive Disorder
Location(s): Taiwan
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Psilocybin and Depression
Start Date: Sep 01, 2018 - Last Update: December 21, 2017
Conditions: Severe Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine
Start Date: Sep 01, 2018 - Last Update: April 23, 2021
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Treatment Resistant MDD
Start Date: Sep 01, 2018 - Last Update: July 16, 2019
Conditions: Depressive Disorder, Major
Location(s): Israel
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Trial Amsterdam (KETA), pilot
Start Date: Aug 20, 2018 - Last Update:
Conditions: (acute) suicidality, depression, personality disorders, substance use disorder. (acute) suïcidaliteit, depressie, persoonlijkheidsstoornissen, middelenmisbruik
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: Comparative bioavailability assessment between 4 x 60 mg R107 tablets administered orally and 0.5mg/kg ketamine IV infusion over 40 minutes in healthy male and female participants under fasting conditions.
Start Date: Jul 18, 2018
Conditions: Depression, Anxiety
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care
Start Date: Jul 16, 2018 - Last Update: May 6, 2022
Conditions: Depression, Cancer, Palliative Care
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Comparative bioavailability assessment between R107 tablet and 60 mg ketamine IV solution administered orally in healthy male and female participants under fasting conditions.
Start Date: Jul 13, 2018
Conditions: Depression, Anxiety
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries
Start Date: Jun 27, 2018 - Last Update: January 12, 2022
Conditions: Pain, Postpartum Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse
Start Date: May 01, 2018 - Last Update: July 13, 2021
Conditions: Suicidal Ideation, Depression, Alcohol Abuse
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effect of Ketamine in Depressive Symptoms of Elderly Patients With Visual Impairment.
Start Date: Apr 15, 2018 - Last Update: February 28, 2019
Conditions: Depression in Old Age, Ketamine
Location(s): Mexico
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin vs. escitalopram for major depressive disorder: comparative mechanisms
Start Date: Apr 09, 2018
Conditions: Major Depressive Disorder
Location(s): United Kingdom
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression
Start Date: Apr 03, 2018 - Last Update: January 21, 2020
Conditions: Depressive Disorder
Location(s): Brazil
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
Start Date: Feb 27, 2018 - Last Update: July 20, 2022
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Respiratory Depression During an Analgosedation Combining Remifentanil and Ketamine in TCI for Oocyte Retrieval
Start Date: Feb 12, 2018 - Last Update: March 13, 2018
Conditions: Oocyte Retrieval, Sedation, Conscious, Ventilatory Depression
Location(s): Belgium
Source: clinicaltrials.gov
short summary

Entheogen: mdma
Study Title: Effects of an 8-day Advanced Meditation, Samyama on Physical, Psychological and Spiritual Wellbeing ,and Associated Neural Mechanisms
Start Date: Jan 19, 2018 - Last Update: February 3, 2022
Conditions: Mental Health Wellness 1, Happiness, Depression, Consciousness, Level Altered, Ecstasy, Dietary Habits, Stress, Inflammatory Bowel Diseases
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Sequential Therapy for the Treatment of Severe Bipolar Depression.
Start Date: Jan 15, 2018 - Last Update: May 25, 2021
Conditions: Bipolar Depression, Suicidal Ideas, Suicidal Ideation, Suicide, Attempted
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
Start Date: Jan 05, 2018 - Last Update: January 7, 2021
Conditions: Distress, Depression, Grief
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intravenous Ketamine Plus Neurocognitive Training for Depression
Start Date: Dec 01, 2017 - Last Update: December 17, 2021
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine
Start Date: Nov 30, 2017 - Last Update: August 16, 2018
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression
Start Date: Nov 23, 2017 - Last Update: December 13, 2021
Conditions: Perinatal Depression, Ketamine, Cesarean Delivery, Postpartum Depression
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effects of S-ketamine on brain activation in healthy women, healthy women prone to depression and fibromyalgia patients.
Start Date: Nov 07, 2017 - Last Update:
Conditions: Ketamine, fMRI, fibromyalgia, depression
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)
Start Date: Sep 14, 2017 - Last Update: July 24, 2020
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: ECT With Ketamine Anesthesia vs High Intensity Ketamine With ECT Rescue for Treatment-Resistant Depression
Start Date: Sep 01, 2017 - Last Update: August 10, 2021
Conditions: Treatment Resistant Depression, Ketamine
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Single dose ketamine pharmacokinetic-pharmacodynamic relationships in healthy volunteers
Start Date: Sep 01, 2017
Conditions: major depressive disorder, post traumatic stress disorder, obsessive compulsive disorder, generalized anxiety disorder, social phobia
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin in Major Depressive Disorder
Start Date: Aug 10, 2017 - Last Update: December 15, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as an adjunctive therapy for Major Depression - a randomised controlled pilot trial: The KARMA-Dep Trial
Start Date: Jul 24, 2017
Conditions: Depression
Location(s): Ireland
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: Ketamine and Postoperative Depressive Symptom-PASSION
Start Date: Jul 05, 2017 - Last Update: July 7, 2020
Conditions: Ketamine; Depressive Symptom; Neurosurgery; Perioperative Period
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.
Start Date: Jun 01, 2017 - Last Update: March 15, 2022
Conditions: Major Depression, Bipolar I Disorder, Bipolar II Disorder, Unipolar Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
Start Date: May 25, 2017 - Last Update: July 7, 2022
Conditions: Healthy Volunteer, Major Depressive Disorder, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Dexamethasone and Ketamine on Change of Postoperative Mood
Start Date: May 02, 2017 - Last Update: June 21, 2017
Conditions: Depressive Symptoms
Location(s): Korea, Republic of
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Investigation of Antidepressant Efficacy of Oral Ketamine Treatment
Start Date: Apr 24, 2017 - Last Update: September 3, 2019
Conditions: Major Depressive Episode
Location(s): Austria
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
Start Date: Apr 07, 2017 - Last Update: March 28, 2022
Conditions: Treatment Resistant Depression, Electroconvulsive Therapy, ECT, Ketamine, Psychiatric Disorder, Depression, Major Depressive Disorder, Major Depressive Episode, Unipolar Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine and Nitroprusside for Depression
Start Date: Feb 14, 2017 - Last Update: July 2, 2020
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Open Label Ketamine Treatment for Major Depressive Disorder in Veterans
Start Date: Jan 31, 2017 - Last Update: October 6, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant Depression
Start Date: Jan 01, 2017 - Last Update: February 5, 2020
Conditions: Depressive Disorder, Major
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer
Start Date: Dec 20, 2016 - Last Update: November 6, 2018
Conditions: Cancer, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The UTHealth Ketamine Project
Start Date: Nov 07, 2016 - Last Update: November 24, 2020
Conditions: Treatment Resistant Depression, Major Depressive Disorder, Bipolar Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Reversal of opioid-induced respiratory depression (OIRD) by ketamine in healthy volunteers
Start Date: Oct 21, 2016 - Last Update:
Conditions: ketamine; opioid-induced respiratory depression
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients
Start Date: Oct 14, 2016 - Last Update: January 13, 2022
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Orale ketamine als aanvullende behandeling bij patiënten met een therapieresistente depressie
Start Date: Oct 01, 2016 - Last Update:
Conditions: Treatment-resistant major depressive disorder, therapie resistente depressie
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: A single and multiple dose safety and tolerability study of oral ketamine in healthy volunteer and patients with a history of depression or anxiety.
Start Date: Sep 29, 2016
Conditions: Depression, Anxiety
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
Start Date: Sep 08, 2016 - Last Update: January 8, 2021
Conditions: Depression
Location(s): France
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression
Start Date: Sep 01, 2016 - Last Update: October 21, 2016
Conditions: Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)
Start Date: Sep 01, 2016 - Last Update: April 24, 2018
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers
Start Date: Aug 15, 2016 - Last Update: November 6, 2018
Conditions: Head and Neck Cancer, Pancreatic Cancer, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study to Decrease Suicidal Thinking Using Ketamine
Start Date: Aug 01, 2016 - Last Update: September 3, 2019
Conditions: Depression, Suicide
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Emergency Ketamine Treatment of Suicidal Ideation
Start Date: Aug 01, 2016 - Last Update: August 5, 2016
Conditions: Depression, Suicidal Ideation, Suicidal Impulses
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Adult Depression Study
Start Date: Jul 22, 2016
Conditions: Major Depressive Disorder
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects
Start Date: Jul 01, 2016 - Last Update: April 23, 2018
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression
Start Date: Jun 01, 2016 - Last Update: May 13, 2016
Conditions: Treatment Resistant Depression
Location(s): Israel
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
Start Date: May 01, 2016 - Last Update: September 7, 2018
Conditions: Major Depressive Disorder, Alcohol Use Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter
Start Date: May 01, 2016 - Last Update: October 15, 2018
Conditions: Depression, Ketamine
Location(s): Austria
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Imaging SV2A in Mood Disorders
Start Date: Apr 01, 2016 - Last Update: April 14, 2022
Conditions: Major Depressive Disorder, Post-Traumatic Stress Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intra-nasal vs. Intra-venous Ketamine Administration
Start Date: Apr 01, 2016 - Last Update: October 28, 2020
Conditions: Major Depressive Disorder
Location(s): Israel
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia
Start Date: Apr 01, 2016 - Last Update: June 28, 2021
Conditions: Depression, Delirium, Seizures, Cognitive Disorders
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects
Start Date: Mar 01, 2016 - Last Update: July 16, 2020
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Anesthesia for Improvement of Depression in ECT
Start Date: Mar 01, 2016 - Last Update: June 6, 2018
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Depression: An MRI Study
Start Date: Mar 01, 2016 - Last Update: April 16, 2019
Conditions: Depression, Anxious Depression, Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: What is the difference in the safety of Ketamine versus Propofol when used to sedate Acute Psychiatric/ Psychotic Patients who require Aeromedical Retrieval?
Start Date: Jan 09, 2016
Conditions: Suicidal Ideation, Depression, Acute Psychosis, Schizophrenia, Attempted Suicide, Post Natal Depression, Self Harm, Personality Disorder, Bipolar Disorder
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: A randomised controlled study of an N-Methyl-D-Aspartate antagonist in major depression
Start Date: Jan 08, 2016
Conditions: Depression, Major depressive disorder
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.
Start Date: Jan 01, 2016 - Last Update: July 26, 2017
Conditions: Major Depressive Disorder, Bipolar I Disorder, Bipolar II Disorder, Bipolar Depression, Suicidal Ideation
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms
Start Date: Dec 01, 2015 - Last Update: February 15, 2018
Conditions: Depression, Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Neurobiology of Suicide
Start Date: Dec 01, 2015 - Last Update: July 11, 2022
Conditions: Healthy Volunteers, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Relapse Prevention in Recurrent Depressive Disorder
Start Date: Dec 01, 2015 - Last Update: January 13, 2020
Conditions: Depression, Relapse, Recurrent Depressive Disorder, Major Depressive Disorder
Location(s): Ireland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy
Start Date: Oct 01, 2015 - Last Update: April 28, 2021
Conditions: Depressive Disorder
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Treatment Resistant Late-Life Depression
Start Date: Oct 01, 2015 - Last Update: January 11, 2022
Conditions: Treatment Resistant Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Infusion for Adolescent Depression and Anxiety
Start Date: Oct 01, 2015 - Last Update: July 14, 2020
Conditions: Major Depressive Disorder, Anxiety Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder
Start Date: Sep 01, 2015 - Last Update: February 19, 2018
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression
Start Date: Aug 01, 2015 - Last Update: August 29, 2019
Conditions: Treatment Resistant Depression, Major Depressive Disorder, Severe Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Spreading Depolarization and Ketamine Suppression
Start Date: Jul 01, 2015 - Last Update: October 25, 2017
Conditions: Cortical Spreading Depolarization, Cortical Spreading Depression, Subarachoid Hemorrhage, Traumatic Brain Injury
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intranasal Ketamine for Late-Life Depression and Suicidal Ideation
Start Date: Jul 01, 2015 - Last Update: March 3, 2017
Conditions: Depression, Suicide, Suicidal Ideation
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Perioperative Ketamine to Reduce Postoperative Delirium and Depression - The RECOGNISED Study
Start Date: May 06, 2015
Conditions: Depression , Delirium, Postoperative Cognitive Dysfunction
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Ketamine Infusions for PTSD and Treatment-Resistant Depression
Start Date: May 01, 2015 - Last Update: May 14, 2019
Conditions: Depressive Disorder, Treatment-Resistant, Stress Disorders, Post-Traumatic
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome
Start Date: Apr 20, 2015 - Last Update: July 28, 2022
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Studying the antidepressant effects of intravenous ketamine in patients with major depressive disorder
Start Date: Apr 06, 2015
Conditions: Major Depressive Disorder
Location(s): Singapore
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Efficacy of Repeated Ketamine Infusions for Treatment-resistant Depression
Start Date: Apr 01, 2015 - Last Update: June 7, 2022
Conditions: Treatment-resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Depression Relapse Prevention Following ECT
Start Date: Apr 01, 2015 - Last Update: May 6, 2021
Conditions: Depression
Location(s): Ireland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Trial for the Treatment of Depression
Start Date: Mar 01, 2015 - Last Update: March 27, 2015
Conditions: Unipolar Depression
Location(s): Australia
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine
Start Date: Feb 01, 2015 - Last Update: March 1, 2017
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder
Start Date: Feb 01, 2015 - Last Update: December 19, 2019
Conditions: Depressive Disorder, Major
Location(s): Sweden
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Assessing the subjective intensity of oral psilocybin in patients with treatment-resistant depression: A Pilot Study
Start Date: Jan 07, 2015
Conditions: Major depressive disorder
Location(s): United Kingdom
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: A Multimodal Neuroimaging Study of Brain Activation Patterns Under Ketamine
Start Date: Jan 01, 2015 - Last Update: March 20, 2019
Conditions: Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy
Start Date: Jan 01, 2015 - Last Update: December 2, 2014
Conditions: Depressive Symptoms, Impaired Cognition, Electroconvulsive Therapy
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)
Start Date: Dec 01, 2014 - Last Update: June 19, 2018
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy
Start Date: Oct 01, 2014 - Last Update: March 16, 2020
Conditions: Pain, Postoperative Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine's Actions on Rumination Mechanisms as an Antidepressant
Start Date: Sep 01, 2014 - Last Update: December 7, 2020
Conditions: Remission in Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Depression and Suicide Risk
Start Date: Sep 01, 2014 - Last Update: August 11, 2017
Conditions: Depression, Suicide
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine in Adolescents With Treatment-Resistant Depression
Start Date: Sep 01, 2014 - Last Update: January 27, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Infusions for Major Depression Disorder
Start Date: Aug 01, 2014 - Last Update: August 29, 2014
Conditions: Depressive Disorder, Major
Location(s): Israel
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy
Start Date: Jul 01, 2014 - Last Update: October 20, 2014
Conditions: Depressive Disorder
Location(s): Turkey
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Biomarkers of Fast Acting Therapies in Major Depression
Start Date: Jun 01, 2014 - Last Update: August 28, 2019
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
Start Date: May 01, 2014 - Last Update: September 21, 2016
Conditions: Depressive Disorder, Treatment-Resistant
Location(s): Mexico
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Alcohol (in Treatment-Resistant Depression)
Start Date: Apr 23, 2014 - Last Update: April 21, 2022
Conditions: Magnetic Resonance Imaging, Major Depression, Alcoholism
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ayahuasca
Study Title: Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression
Start Date: Feb 01, 2014 - Last Update: February 17, 2017
Conditions: Major Depression
Location(s): Brazil
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder
Start Date: Feb 01, 2014 - Last Update: January 27, 2017
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Evaluation of the Pharmacokinetics of Sublingual IPX237 in Healthy Volunteers
Start Date: Jan 07, 2014
Conditions: Depression
Location(s): Australia, United States of America
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression
Start Date: Jan 01, 2014 - Last Update: April 2, 2020
Conditions: Suicidal Ideation, Major Depressive Disorder, Healthy Participants
Location(s): Israel
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures
Start Date: Jan 01, 2014 - Last Update: February 25, 2021
Conditions: Mechanical Ventilation, Airway Patency, Respiratory Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Use in Electroconvulsive Therapy
Start Date: Jan 01, 2014 - Last Update: March 19, 2015
Conditions: Depression
Location(s): Brazil
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients
Start Date: Dec 01, 2013 - Last Update: September 14, 2018
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Evaluation of the Pharmacokinetics of IPX237 Formulations in Healthy Volunteers
Start Date: Sep 12, 2013
Conditions: Depression
Location(s): Australia, United States of America
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Ketamine for Suicidality in Bipolar Depression
Start Date: Sep 01, 2013 - Last Update: March 11, 2020
Conditions: Bipolar Disorder, Major Depressive Episode, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy
Start Date: Sep 01, 2013 - Last Update: September 13, 2017
Conditions: Treatment Resistant Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population
Start Date: Sep 01, 2013 - Last Update: March 17, 2015
Conditions: Depressive Disorder,, Treatment-Resistant Depression
Location(s): Mexico
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling
Start Date: Jul 01, 2013 - Last Update: September 8, 2021
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Plus Lithium in Treatment-Resistant Depression
Start Date: Jul 01, 2013 - Last Update: July 31, 2018
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: An Open Prospective Trial of IV Ketamine in Suicidal Adolescents
Start Date: Jun 01, 2013 - Last Update: January 29, 2014
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression
Start Date: Jun 01, 2013 - Last Update: June 30, 2015
Conditions: Depressive Disorder
Location(s): Belgium, France, Netherlands, Spain
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Action of Ketamine in Treatment-Resistant Depression
Start Date: May 01, 2013 - Last Update: June 26, 2018
Conditions: Treatment-resistant Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Trial of Ketamine and Lithium Therapy in Bipolar Depression
Start Date: Jan 01, 2013 - Last Update: March 9, 2020
Conditions: Bipolar Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder
Start Date: Jan 01, 2013 - Last Update: April 20, 2017
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: ECT and Memantine.
Start Date: Dec 01, 2012 - Last Update:
Conditions: Electroconvulsive therapy Cognitive side effects Memantine Electroconvulsieve therapie Cognitieve bijwerkingen Memantine Depression Depressie
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: A Study of Ketamine in Patients With Treatment-resistant Depression
Start Date: Aug 06, 2012 - Last Update: June 2, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: PET Imaging of mGLuR5 With Drug Challenge
Start Date: Jun 01, 2012 - Last Update: April 21, 2017
Conditions: Major Depressive Disorder, Post-Traumatic Stress Disorder (PTSD)
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine in the Treatment of Suicidal Depression
Start Date: Jun 01, 2012 - Last Update: March 11, 2020
Conditions: Major Depressive Disorder, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Treatment of Suicidal Ideation With Intravenous Ketamine Infusion
Start Date: May 01, 2012 - Last Update: May 15, 2017
Conditions: Depression, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Treatment Resistant Depression (Pilot)
Start Date: Apr 01, 2012 - Last Update: October 6, 2021
Conditions: Depressive Disorder, Treatment-Resistant
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Infusion for Treatment-resistant Major Depressive Disorder
Start Date: Apr 01, 2012 - Last Update: April 20, 2017
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine in treatment resistant major depression (TRD)
Start Date: Mar 05, 2012
Conditions: Therapy resistant depression
Location(s): Germany
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks
Start Date: Mar 01, 2012 - Last Update: February 24, 2017
Conditions: Major Depressive Disorder
Location(s): France
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Depression and Alcohol Dependence
Start Date: Mar 01, 2012 - Last Update: March 9, 2020
Conditions: Depression, Alcohol Dependence
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Study of Ketamine as an Antidepressant in Major Depressive Disorder
Start Date: Feb 01, 2012 - Last Update: May 4, 2012
Conditions: Major Depressive Disorder
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine in the Treatment of Depression
Start Date: Feb 01, 2012 - Last Update: December 10, 2019
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy
Start Date: Feb 01, 2012 - Last Update: June 6, 2013
Conditions: Major Depression, Electroconvulsive Therapy
Location(s): Turkey
Source: clinicaltrials.gov
short summary

Entheogen: mdma
Study Title: Characterization of the Prosocial and Prosexual Effects of GHB
Start Date: Feb 01, 2012 - Last Update: July 29, 2019
Conditions: Depressive Disorder, Major, Bipolar Disorder, Autistic Disorder
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Subanesthetic IV Bolus Ketamine in the Treatment of Acute Depression
Start Date: Dec 01, 2011 - Last Update: March 4, 2015
Conditions: Acute Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intranasal Ketamine in Treatment-Resistant Depression
Start Date: Oct 01, 2011 - Last Update: February 8, 2017
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study of Ketamine as an Antidepressant
Start Date: Sep 01, 2011 - Last Update: February 22, 2013
Conditions: Major Depressive Episode
Location(s): Australia
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Anesthesia in Electroconvulsive Therapy
Start Date: May 01, 2011 - Last Update: August 8, 2013
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Rapid depression treatment in cancer patients
Start Date: Mar 23, 2011
Conditions: Major depressive disorder, Cancer
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: The Use of Ketamine as an Anaesthetic During Electroconvulsive Therapy
Start Date: Mar 01, 2011 - Last Update: September 8, 2016
Conditions: Depression
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Neuromodulation to Facilitate the Effect of Ketamine
Start Date: Jan 01, 2011 - Last Update: March 22, 2013
Conditions: Depression, Chronic Pain, Substance Abuse
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression
Start Date: Nov 01, 2010 - Last Update: May 22, 2017
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression
Start Date: Jun 01, 2010 - Last Update: August 10, 2017
Conditions: Unipolar Depression, Bipolar Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Study of Depression-Ketamine-Brain Function
Start Date: Jun 01, 2010 - Last Update: December 7, 2015
Conditions: Major Depression
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression
Start Date: Apr 01, 2010 - Last Update: August 30, 2013
Conditions: Major Depression, Bipolar Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Low Mood States in the ER
Start Date: Apr 01, 2010 - Last Update: August 24, 2020
Conditions: Depression, Suicide Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: mdma
Study Title: Fluoxetine and the developing brain.
Start Date: Feb 01, 2010 - Last Update:
Conditions: Major depression/depressie, SSRI, fluoxetine, serotonine, development/ontwikkeling
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: Pilot study for the rapid alleviation of depression in depressed alcohol dependent persons using ketamine
Start Date: Jan 09, 2010
Conditions: depression, alcohol dependence
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: The effect of ketamine and methadon on healthy volunteers with special focus on painscore, sedation, ventilatory depression and change of pupil diameter.
Start Date: Jan 02, 2010 - Last Update:
Conditions: analgesia respiratory depression pijnstilling analgesie ademhalingsdepressie
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects
Start Date: Dec 01, 2009 - Last Update: October 13, 2014
Conditions: Depression
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
Start Date: Jan 01, 2009 - Last Update: February 14, 2018
Conditions: Stress Disorders, Post-Traumatic, PTSD, Depression, Anxiety Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Optimization of IV Ketamine for Treatment Resistant Depression
Start Date: Nov 01, 2008 - Last Update: January 31, 2014
Conditions: Major Depressive Disorder (MDD), Treatment Resistant Depression (TRD)
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as an Anaesthetic Agent in Electroconvulsive Therapy (ECT)
Start Date: Apr 01, 2008 - Last Update: March 29, 2013
Conditions: Major Depressive Episode
Location(s): Australia
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Frequency Treatment for Major Depressive Disorder
Start Date: Mar 01, 2008 - Last Update: June 6, 2011
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Continuation Ketamine in Major Depression
Start Date: Oct 01, 2007 - Last Update: May 23, 2014
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psychopharmacology of Psilocybin in Cancer Patients
Start Date: Apr 01, 2007 - Last Update: July 19, 2018
Conditions: Depressive Symptoms, Anxiety, Cancer
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Altered breathing with postoperative pain relief
Start Date: Jan 06, 2007
Conditions: Obesity, Respiratory Depression, Postoperative analgesia
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Research Study for Major Depressive Disorder: Investigation of Glutamate Medications
Start Date: Dec 01, 2006 - Last Update: July 31, 2019
Conditions: Major Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effect of intra-operative sedation with low-doses of S-Ketamine on depression in the elderly: randomized double-blind controlled trial
Start Date: May 20, 2006
Conditions: Mental Depression
Location(s): Brazil, Distrito Federal
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Rapid Antidepressant Effects of Ketamine in Major Depression
Start Date: Jul 26, 2004 - Last Update: October 12, 2018
Conditions: Depression, Mood Disorders, Major Depresssion
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: mdma
Study Title: An Open-Label, Phase 2, Feasibility Study of Manualized MDMA-Assisted Psychotherapy in Subjects with Major Depressive Disorder
Start Date:
Conditions: Major Depressive Disorder
Location(s): Norway
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: The safety and efficacy of psilocybin as an adjunctive therapy in participants with treatment-resistant depression
Start Date:
Conditions: treatment resistant depression
Location(s): Ireland
Source: www.clinicaltrialsregister.eu
short summary



Total execution time in seconds: 0.053834915161133